Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (321-330 of 366) with videos related to

Pageof 37
Sort By:
Cell Transplantation|March 7, 1998
Generation of primary peptide-specific CD8+ cytotoxic T-lymphocytes in vitro using allogeneic dendritic cellsM V Peshwa, C Benike, M Dupuis, et al.
Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individualsM Dupuis, M V Peshwa, C Benike, et al.
Hepatology (Baltimore, Md.)|November 1, 1981
Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver diseaseL L Andres, V K Sawhney, G H Scullard, et al.
The Journal of Infectious Diseases|December 8, 1998
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229J M Schapiro, J Lawrence, R Speck, et al.
The Journal of Infectious Diseases|February 10, 1999
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study GroupJ P Kleim, M Winters, A Dunkler, et al.
Antiviral Therapy|June 10, 2000
Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDSM A Winters, J D Baxter, D L Mayers, et al.
AIDS Research and Human Retroviruses|May 20, 1998
A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patientsS K Kundu, E Engleman, C Benike, et al.
The Journal of Infectious Diseases|June 1, 1981
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinosideG H Scullard, R B Pollard, J L Smith, et al.
Journal of Chromatography|May 11, 1984
High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasmaG A Smith, K M Giacomini, C T Smith, et al.
Pageof 37

Showing results (321-330 of 366) with videos related to

Sort By:
Pageof 37
Cell Transplantation|March 7, 1998
Generation of primary peptide-specific CD8+ cytotoxic T-lymphocytes in vitro using allogeneic dendritic cellsM V Peshwa, C Benike, M Dupuis, et al.
Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individualsM Dupuis, M V Peshwa, C Benike, et al.
Hepatology (Baltimore, Md.)|November 1, 1981
Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver diseaseL L Andres, V K Sawhney, G H Scullard, et al.
The Journal of Infectious Diseases|December 8, 1998
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229J M Schapiro, J Lawrence, R Speck, et al.
The Journal of Infectious Diseases|February 10, 1999
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study GroupJ P Kleim, M Winters, A Dunkler, et al.
Antiviral Therapy|June 10, 2000
Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDSM A Winters, J D Baxter, D L Mayers, et al.
AIDS Research and Human Retroviruses|May 20, 1998
A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patientsS K Kundu, E Engleman, C Benike, et al.
The Journal of Infectious Diseases|June 1, 1981
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinosideG H Scullard, R B Pollard, J L Smith, et al.
Journal of Chromatography|May 11, 1984
High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasmaG A Smith, K M Giacomini, C T Smith, et al.
Pageof 37